Search results
Results from the Think 24/7 Content Network
MDAI ( 5,6-methylenedioxy-2-aminoindane) is a drug developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a non- neurotoxic and highly selective serotonin releasing agent (SSRA) in vitro and produces entactogen effects in humans.
3,4-Methylenedioxyamphetamine (also known as MDA and sass) is an empathogen-entactogen, psychostimulant, and psychedelic drug of the amphetamine family that is encountered mainly as a recreational drug. In its pharmacology, MDA is a serotonin–norepinephrine–dopamine releasing agent (SNDRA). In most countries, the drug is a controlled ...
2-Aminoindane ( 2-AI) is a research chemical with applications in neurologic disorders and psychotherapy that has also been sold as a designer drug. [1] It acts as a selective substrate for NET and DAT. [2] [3]
The 1945–1946 War in Vietnam, codenamed Operation Masterdom [3] by the British, and also known as the Southern Resistance War (Vietnamese: Nam Bộ kháng chiến) [4] [5] by the Vietnamese, was a post–World War II armed conflict involving a largely British-Indian and French task force and Japanese troops from the Southern Expeditionary Army Group, versus the Vietnamese communist movement ...
6-APB ( 6- (2-aminopropyl)benzofuran) is an empathogenic psychoactive compound of the substituted benzofuran and substituted phenethylamine classes. [ 1] 6-APB and other compounds are sometimes informally called "Benzofury" in newspaper reports. It is similar in structure to MDA, but differs in that the 3,4- methylenedioxyphenyl ring system has ...
Website. doc .mo .gov. The Missouri Department of Corrections is the state law enforcement agency that operates state prisons in the U.S. state of Missouri. It has its headquarters in Missouri's capital of Jefferson City . The Missouri Department of Corrections has 21 facilities statewide, including two community release centers.
A serotonin–norepinephrine–dopamine releasing agent ( SNDRA ), also known as a triple releasing agent ( TRA ), is a type of drug which induces the release of serotonin, norepinephrine / epinephrine, and dopamine in the brain and body. SNDRAs produce euphoriant, entactogen, and psychostimulant effects, and are almost exclusively encountered ...
5-Iodo-2-aminoindane ( 5-IAI) is a drug which acts as a releasing agent of serotonin, norepinephrine, and dopamine. [ 2] It was developed in the 1990s by a team led by David E. Nichols at Purdue University. [ 3] 5-IAI fully substitutes for MDMA in rodents and is a putative entactogen in humans. [ 3] Unlike related aminoindane derivatives like ...